Resources

This lessons learned documents provides an overview of Myanmar's fortified rice project spanning six years of project implementation. The brief gives an overview of achievements and challenges under key critical factors that underpin the progress of introducing fortified rice in Myanmar: 1) Key relationships and actors; 2) Public and social-sector interventions; 3) Competitive pricing; and 4) Marketing and media. Recommendations for scale-up are provided in the brief to pave the way forward.

The DMPA-SC Resource Library has been developed to provide comprehensive information on the self-injectable contraceptive subcutaneous DMPA (DMPA-SC, brand name Sayana® Press). The site features evidence, country introduction experiences, service delivery and advocacy tools, and more for global- and country-level family planning implementers and decision-makers.It is hosted by the Injectables Access Collaborative, an initiative led by PATH in partnership with the Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, and JSI. The Access Collaborative provides data-driven technical assistance, coordination, resources, and tools to ensure that women and girls have increased access to DMPA-SC and self-injection as part of an expanded range of contraceptive methods, delivered through informed choice programming.For more information, sign up for our mailing lists or contact FPoptions@path.org.

Clinical decision support algorithms (CDSAs) are digitized tools that combine an individual’s health information with the health worker’s knowledge and clinical protocols to assist in making diagnosis and treatment decisions. They analyze patient data, providing prompts and reminders that help health care workers deliver a range of services within a continuum of care.Despite several initiatives underway around the use of these digital tools in low-resource settings, there remains a lack of awareness of their impact and cost-effectiveness at the national level, as well as a growing need to streamline how health data is collected and used for decision-making. Though more research is needed, initial evidence suggests that CDSAs can reduce barriers to quality of care and, ultimately, health disparities, leading to greater health impact.This fact sheet summarizes key considerations that countries, implementing partners, and donors should keep in mind when planning for CDSA implementation. It also describes the work PATH, as part of its Tools for Integrated Management of Childhood Illness initiative, is leading to adapt CDSAs for country context and incorporate them into health systems to enable better and more targeted patient care.

PATH is working with state governments in India to improve access to COVID-19 testing by building a cost effective, sustainable, and scalable model for testing strategy and capacity.

The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments, and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This report presents findings synthesized across the eight PCE countries in 2020 presenting a comprehensive look at the Global Fund grant cycle. The PCE assessed how business model factors have facilitated or hindered the achievement of objectives during implementation of grants approved during the 2017-19 funding cycle, including around Resilient and Sustainable Systems for Health (RSSH), sustainability and equity, and whether lessons learned during current grants have informed the next funding cycle. The objective of this grant cycle analysis was to understand what, when, why, and how grant investments change over time, including significant factors that influenced the implementation of and changes to the original grant.